UFSP2-CCDC110 Fusion FISH Probe
The UFSP2-CCDC110 Fusion FISH Probe is used to confirm a fusion of the UFSP2 and CCDC110 genes. The fusion of the UFSP2 and CCDC110 genes has been associated with Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| UFSP2-CCDC110-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-RERE | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-REOR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-REGO | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-REGR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-OROR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GORE | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GROR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| UFSP2-CCDC110-20-AQAQ | 20 (40 μL) | 200 μL |
|
UFSP2 Gene Summary
This gene encodes a highly conserved cysteine protease. The protein cleaves two C-terminal residues from ubiquitin-fold modifier 1, a ubiquitin-like post-translational modifier protein. Activation of ubiquitin-fold modifier 1 by the encoded protein exposes a C-terminal glycine residue that allows interaction with other proteins and transfer to its target protein. An allelic variant of this gene has been associated with Beukes hip dysplasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
Gene Name: UFM1 Specific Peptidase 2
Chromosome: CHR4: 186320693 -186347139
Locus: 4q35.1
CCDC110 Gene Summary
The Coiled-coil Domain Containing 110 (CCDC110) gene is located on chr4 :186366337-186392913 at 4q35.1.
Gene Name: Coiled-coil Domain Containing 110
Chromosome: CHR4: 186366337 -186392913
Locus: 4q35.1
Gene Diseases
The UFSP2 CCDC110 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Liver Hepatocellular Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|